对接交流招募丨2026 英国-粤港澳大湾区大会：大健康与生命科学主题分会 UK-Greater Bay Area Healthcare & Life Science Forum 2026

由英中贸易协会主办的英国-粤港澳大湾区大会大健康与生命科学主题分会将于 2026年12月4日（星期五）在深圳举办。论坛将聚焦中英生命科学与医疗健康领域创新合作，围绕产业政策、技术创新、成果转化、跨境合作及生态建设等热点议题展开深入交流，共同探讨如何依托大湾区产业优势，加速英国创新技术和解决方案进入中国市场，并推动双边产业合作迈向更高水平。

The China-Britain Business Council (CBBC) cordially invite you to attend the UK-Greater Bay Area Healthcare & Life Science Forum 2026 on Friday, 4th December in Shenzhen. The forum will bring together key stakeholders from across the UK and the Greater Bay Area to explore emerging opportunities in healthcare, life sciences, medical technology, biopharmaceuticals, innovation commercialisation and cross-border collaboration. The forum aims to provide a high-level platform for dialogue, partnership building and knowledge exchange between industry leaders, policymakers, researchers, investors and innovation enablers.

论坛预计吸引 150余位参会嘉宾，包括来自政府机构、跨国企业、生命科学及医疗健康企业、科研院校、创新平台、投资机构、产业园区以及专业服务机构的代表，共同构建高层次、多元化的国际交流平台。

The event is expected to attract more than 150 delegates, including representatives from government authorities, multinational corporations, healthcare and life sciences companies, universities and research institutions, investment organisations, innovation platforms, industrial parks and professional service firms. More than 15 speakers are expected to contribute insights and best practice from both the UK and China.

13:30–14:00 

嘉宾签到以及暖场视频播放 

Registration and Video

14:00–14:15 嘉宾致辞 Opening Remarks

14:15–14:35 

主旨演讲一：粤港澳大湾区战略发展及产业概览

Keynote Speech I: GBA Strategic & Industrial Overview

14:35–14:55 

主旨演讲二：深耕湾区 · 大健康企业创新实践与跨境合作机遇

Keynote Speech II: Life Science & Healthcare Enterprise Innovation & Cross-border Collaboration

14:55–15:15 

重磅发布：英国-粤港澳大湾区创新中心计划启动仪式

Official Launch: UK-GBA Innovation Hub Initiative

15:15–15:30

茶歇 & 自由交流 Coffee Break & Networking

15:30–16:25 

主题一：技术转化与落地赋能

Panel I: Technology Translation & Industrial Landing

16:30–17:25

主题二：产业生态与可持续合作

Panel II: Ecosystem Building & Sustainable Cross-border Cooperation

17:25–17:30 总结致辞 Closing Remarks

17:30–18:00 项目对接及交流 Match-making Session

英中贸易协会诚挚邀请各类企业、机构及媒体伙伴与我们建立联系，共同探索合作契机与途径。

CBBC cordially invites companies, institutions and organisations, and media to reach out to us and explore potential collaboration opportunities.

请扫描下方二维码查看赞助方案或联系Tina.Tu@cbbc.org

Please scan the QR code below to view the sponsorship pack, or contact Tina.Tu@cbbc.org

请联系：Tina.Tu@cbbc.org

Please contact Tina.Tu@cbbc.org

请联系：Jiayi.Hu@cbbc.org

Please contact Jiayi.Hu@cbbc.org

本次论坛特别设置项目对接及交流（Match-making Session）环节。对于有明确粤港澳大湾区合作需求的英国企业，CBBC将收集企业的项目介绍、市场计划及具体合作诉求，以支持更具针对性的跨境项目对接。欢迎联系 Jessica Dai（jessica.dai@cbbc.org）获取 UK Company Match-making Survey，并提交您的项目及具体合作需求。

A key feature of the Forum will be a dedicated Match-making Session, designed to help turn conversations into practical opportunities.

UK companies with specific ambitions in the Greater Bay Area are invited to submit their company profile, business interests and collaboration requirements, enabling CBBC to support more targeted cross-border business matching. Contact Jessica Dai at jessica.dai@cbbc.org to access the UK Company Match-making Survey.

英国生命科学企业 Alcotox Ltd 长期开展乙醛相关研究，重点关注酒精代谢过程中产生的乙醛及相关健康问题。其技术平台目前涵盖三类方向：Vital x 胶囊及 Splash 液体剂型、功能性啤酒和葡萄酒，以及针对 Asian Flush（酒精性脸红）、肝脏健康、DNA损伤和成瘾问题的研究项目。其中 Vital x 已在英国商业化，功能性啤酒及葡萄酒目前为处于专利申请阶段的原型产品。

合作意向：
 重点寻找医院及临床机构、高校及科研实验室、投资机构、地方政府和产业园区，以及医药、消费健康、饮料和酿造领域的战略企业伙伴，探索投资、联合研究、临床合作、市场准入及未来商业化合作。

Alcotox Ltd is a UK life sciences company conducting research into acetaldehyde, the toxic by-product of alcohol metabolism. Its platform spans Vital x capsules and Splash liquid shots, functional beer and wine, and research programmes covering Asian Flush, liver health, DNA damage and addiction. Vital x is commercially available in the UK, while its functional beer and wine products are currently patent-pending prototypes.

Looking for:
 Hospitals and clinical institutions, universities and research laboratories, investors, government and industrial park authorities, together with strategic corporate partners in pharmaceuticals, consumer health, beverages and brewing. The company is interested in investment, research collaboration, clinical cooperation, market-entry support and future commercialisation opportunities.

Clan Healthcare是英国专业膳食功能性补充剂生产商，生产设施位于牛津，相关产品覆盖儿童健康、慢病管理、抗衰老、辅助生殖及宠物健康等领域，并提供OEM代工及自有品牌合作。

合作意向：
 希望寻找对英国本土生产的膳食补充剂、OTC及化妆品OEM感兴趣的合作伙伴，并对接康养机构、医疗连锁、药房连锁、免税渠道、供应链企业及渠道代理商。

A UK manufacturer of specialist functional dietary supplements with production facilities in Oxford. Its product areas include children's health, chronic-condition management, healthy ageing, assisted reproduction and pet health, alongside private-label manufacturing and own-brand collaboration.

Looking for:
 Partners interested in UK-manufactured OEM products across dietary supplements, OTC products and cosmetics, as well as healthcare providers, pharmacy chains, duty-free channels, supply-chain partners and distributors.

EveryBaby 正在开发一款基于谢菲尔德大学研究成果的手持式宫颈电阻抗频谱（EIS）检测设备。该产品主要面向产科医疗专业人员提供宫颈测量，未来拟进一步用于早产风险评估。目前设备处于商业化前阶段，相关设备验证、临床验证及监管工作正在推进中。

合作意向：

希望重点对接妇产医院、妇产科及产科临床研究团队、医疗器械经销商、高校及科研机构、医疗健康投资机构，以及注册和市场准入专业服务机构，探索临床研究、产品验证、科研合作、渠道拓展、投融资及未来进入中国市场的合作机会。

EveryBaby is developing a handheld cervical Electrical Impedance Spectroscopy (EIS) device, building on research from the University of Sheffield. The initial product is intended to provide cervical measurements for obstetric healthcare professionals, with future development aimed at preterm-birth risk assessment. The device is currently at the pre-commercialisation stage, with device verification, clinical validation and regulatory work under way.

Looking for:

Maternity hospitals, OBGYN and obstetric research teams, medical device distributors, universities and research institutes, healthcare investors, and regulatory and market-entry advisers. EveryBaby is interested in clinical research, product validation, research collaboration, distribution partnerships, investment and future market-entry opportunities in China.

Hammersmith Medicines Research（HMR）总部位于伦敦，是一家拥有超过30年行业经验的早期临床试验机构，专注于高质量的 I 期临床研究。HMR隶属于Nucleus Network。自1993年以来，Nucleus Network已为来自中国、欧洲、日本、韩国及美国等市场的生物科技和制药企业开展超过2,500项 I 期临床试验，其中包括1,500余项首次人体试验，并在国际多中心早期临床研究及监管申报方面积累了丰富经验。

合作意向：

希望对接正在拓展海外市场的中国制药及生物科技企业，为其在英国、美国和澳大利亚开展 I 期及其他早期临床试验提供支持，并协助企业推进全球临床开发及国际化进程。

Hammersmith Medicines Research (HMR), headquartered in London, is an established early-phase clinical research organisation with more than 30 years of industry experience and a strong focus on high-quality Phase I clinical studies. HMR is part of Nucleus Network. Since 1993, Nucleus Network has conducted more than 2,500 Phase I clinical trials for biotechnology and pharmaceutical companies from China, Europe, Japan, South Korea and the United States, including over 1,500 first-in-human studies. It also brings extensive experience in international early-phase clinical development and regulatory submissions.

Looking for:

Chinese pharmaceutical and biotechnology companies seeking to expand internationally and conduct Phase I or other early-phase clinical trials in the UK, the United States and Australia. HMR is interested in supporting Chinese companies with their global clinical development and internationalisation strategies.

英国Sleepup医疗科技是一家专注于失眠治疗与睡眠障碍监测的健康科技企业，通过数字疗法和睡眠监测产品组合，打造覆盖治疗、咨询、监测与教育的综合平台。

合作意向：
 希望对接中国市场的经销商及医院等合作伙伴，探索产品及技术合作机会。

A UK health technology company focused on insomnia treatment and sleep-disorder monitoring, combining digital therapeutics with sleep-monitoring solutions across treatment, consultation, monitoring and education.

Looking for:

Distributors, hospitals and potential partners interested in exploring cooperation opportunities in China.

英国科技企业 Smart Access and Monitoring Ltd 正在开发 SAM，一个面向医疗、社会照护、独立生活、工业及其他安全关键场景的跨行业安全与响应决策治理软件平台。SAM旨在整合现有传感器、设备及其他授权信息来源，识别、评估并响应安全关切。目前项目处于实验室原型开发阶段。

合作意向：
 希望对接医院及临床机构、高校及科研实验室、投资机构，以及知识产权、法律和监管等专业服务机构，重点探索早期联合研发、独立评估、技术合作及未来技术许可机会，而非现阶段立即进行商业部署。

Smart Access and Monitoring Ltd is developing SAM, a cross-sector safety and response decision-governance software platform. It is intended to bring together information from existing sensors, devices and other authorised sources to support decision-making, response coordination and follow-through on unresolved safety concerns. Potential applications include healthcare, social care, independent living and safety-critical environments. SAM is currently at laboratory prototype stage. 

Looking for:
 Hospitals and clinical institutions, universities and research laboratories, investors, industry associations and professional service providers (IP, legal, regulatory consulting), with a particular interest in early-stage joint research, independent evaluation, technology collaboration and potential future licensing, rather than immediate commercial deployment.

伯明翰大学是一所位于英国伯明翰的研究型大学。此次拟重点围绕生物技术与创新药物、医疗器械及体外诊断、数字医疗与人工智能医疗、医疗服务、生命科学研发外包，以及医学与健康领域的科研合作，与粤港澳大湾区相关机构开展交流。目前，拟对接的合作方向主要处于概念或实验室原型阶段。

合作意向：

希望重点对接生命科学企业、医院及临床机构、高校和科研实验室，探索技术许可、联合研发、临床研究及学术科研合作机会。项目尤其关注建立可信、长期的科研合作议程，并倾向于通过会后引荐及邮件对接的方式推进后续交流。

The University of Birmingham is a UK-based research university seeking engagement with Greater Bay Area organisations across biotechnology and innovative pharmaceuticals, medical devices and in-vitro diagnostics, digital health and AI-enabled medicine, healthcare delivery, life sciences research outsourcing, and wider medicine and health research. The proposed areas of engagement are currently primarily at the concept or laboratory-prototype stage.

Looking for:

Life science companies, hospitals and clinical institutions, universities and research laboratories interested in technology licensing, joint research and development, clinical research, and wider academic collaboration. The University is particularly interested in developing a trusted, long-term research agenda with Greater Bay Area partners and would welcome post-Forum introductions and email connections to support further discussion.

www.cbbc.org

The China-Britain Business Council (CBBC) is the UK’s national business network promoting trade and investment with China. We have been at the heart of the UK-China relationship for 72 years and are widely recognised as the independent voice of British businesses working with China. Our objective is to support the growth of British trade and investment with China and Chinese companies expanding and investing in the UK. Our diverse membership includes leading UK companies and universities, many of the UK’s most dynamic SMEs, and an ever-increasing number of Chinese companies exporting to and investing in the UK.

英中贸易协会（CBBC）是英国促进对华贸易和投资的国家级商业贸易网络。72年以来，我们一直处在行动的核心位置，积极参与两国在每个行业和地区的合作，被广泛认为是英国企业与中国合作的独立声音。我们的目标是支持英国对华贸易和投资的增长，以及中国企业在英国的扩张和投资。我们的会员包括众多英国领先的公司与知名大学、英国最具活力的中小企业，以及越来越多向英国出口和在英国投资的中国企业等。